These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 14526770)

  • 1. Cardiovascular genomics.
    Hall SW
    N Engl J Med; 2003 Oct; 349(14):1387-8; author reply 1387-8. PubMed ID: 14526770
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor V Leiden and increased risk for arterial thrombotic disease in young Brazilian patients.
    de Paula Sabino A; Ribeiro DD; Carvalho Md; Cardoso J; Dusse LM; Fernandes AP
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):271-5. PubMed ID: 16651869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of factor V Leiden in a population of Israeli Arabs.
    Rosen E; Renbaum P; Heyd J; Levy-Lahad E
    Thromb Haemost; 1999 Dec; 82(6):1768. PubMed ID: 10613668
    [No Abstract]   [Full Text] [Related]  

  • 4. A polymorphism nt 1628G-->A (R485K) in exon 10 of the coagulation factor V gene may be a risk factor for thrombosis in the indigenous Thai population.
    Hiyoshi M; Arnutti P; Prayoonwiwat W; Nathalang O; Suwanasophon C; Kokaseam R; Hashimoto S; Takubo T; Tagawa S; Fukui M; Tatsumi N
    Thromb Haemost; 1998 Oct; 80(4):705-6. PubMed ID: 9798997
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of prothrombotic mutations and polymorphisms in children who developed thrombosis in the perioperative period of congenital cardiac surgery.
    Ozbek N; Ataç FB; Yildirim SV; Verdi H; Yazici C; Yilmaz BT; Tokel NK
    Cardiol Young; 2005 Feb; 15(1):19-25. PubMed ID: 15831156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and acquired prothrombotic risk factors and sudden hearing loss.
    Capaccio P; Ottaviani F; Cuccarini V; Bottero A; Schindler A; Cesana BM; Censuales S; Pignataro L
    Laryngoscope; 2007 Mar; 117(3):547-51. PubMed ID: 17334320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectin haplotypes and the risk of venous thrombosis: influence of linkage disequilibrium with the factor V Leiden mutation.
    Uitte de Willige S; De Visser MC; Vos HL; Houwing-Duistermaat JJ; Rosendaal FR; Bertina RM
    J Thromb Haemost; 2008 Mar; 6(3):478-85. PubMed ID: 18182036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V Leiden: an overview.
    Shaw DM
    Clin Lab Sci; 2006; 19(4):218-21. PubMed ID: 17181126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does factor V Asp79His (409 G/C) polymorphism influence factor V and APC resistance levels?
    Lunghi B; Scanavini D; Girelli D; Legnani C; Bernardi F
    J Thromb Haemost; 2005 Feb; 3(2):415-6. PubMed ID: 15670066
    [No Abstract]   [Full Text] [Related]  

  • 10. Absence of length polymorphism within the 31 tandem repeats of the B domain of factor V.
    Escoffre-Barbe M; Alhenc-Gelas M; Aiach M; Emmerich J
    Thromb Haemost; 1996 May; 75(5):862-3. PubMed ID: 8725740
    [No Abstract]   [Full Text] [Related]  

  • 11. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. About the significance or the insignificance of the factor XII C46T polymorphism: a rebuttal.
    Girolami A; Vettore S; Lombardi AM
    J Thromb Haemost; 2007 Oct; 5(10):2162-3; authors reply 2163-5. PubMed ID: 17883708
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor V Kuwait alias factor V R3: a rare polymorphism of uncertain functional significance.
    Castoldi E; Lunghi B; Rosing J; Bernardi F
    Med Princ Pract; 2007; 16(3):244-5; author reply 246. PubMed ID: 17409764
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cerebral venous thrombosis and factor V Leiden].
    Medrano V; Mallada-Frechín J; Fernández-Izquierdo S; Piqueras-Rodríguez L
    Rev Neurol; 2006 Jul 1-15; 43(1):49-50. PubMed ID: 16807872
    [No Abstract]   [Full Text] [Related]  

  • 15. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A; Egin Y; Cam R; Akar N
    Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.
    Kim RJ; Becker RC
    Am Heart J; 2003 Dec; 146(6):948-57. PubMed ID: 14660985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of inherited prothrombotic risk factors in 134 consecutive patients with von Willebrand disease.
    Franchini M; Veneri D; Poli G; Manzato F; Salvagno GL; Lippi G
    Am J Hematol; 2006 Jun; 81(6):465-7. PubMed ID: 16680739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutation in factor II and factor V gene in patients with peripheral arterial occlusive disease].
    Abukishe A; Brandt M; Hedderich J; Hirt S; Lentz S; Schäfer H; Walluscheck K; Cremer J; Bruhn HD
    Hamostaseologie; 2006 Aug; 26(3):197-200. PubMed ID: 16906235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V mutations in Iranian patients with activated protein C resistance and venous thrombosis.
    Chegeni R; Kazemi B; Hajifathali A; Pourfathollah A; Lari GR
    Thromb Res; 2007; 119(2):189-93. PubMed ID: 16542711
    [No Abstract]   [Full Text] [Related]  

  • 20. Factor V Leiden in Mexican pediatric patients with thrombosis.
    Parra-Ortega I; Sanchez-Huerta JL; Lopez-Martinez B
    Clin Appl Thromb Hemost; 2009; 15(4):477. PubMed ID: 19726419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.